1.Forman SJ，Negrin RS，Antin JH，et al. Thomas’ Hematopoietic cell transplantation .5th ed. Oxford：Wiley Blackwell，2016.

2.Bacigalupo A，Ballen K，Rizzo D，et al. Defining the intensity of conditioning regimens：working definitions. Biol Blood Marrow Transplant，2009，15（12）：1628-1633.

3.Lee JH，Joo YD，Kim H，et al. Randomized trial of myeloablative conditioning regimens：busulfan plus cyclophosphamide versus busulfan plus fludarabine. J Clin Oncol，2013，31（6）：701-709.

4.Scott BL，Pasquini MC，Logan B，et al. Results of a phase Ⅲ randomized，multi-center study of allogeneic stem cell transplantation after high versus reduced intensity conditioning in patients with myelodysplastic syndrome（MDS） or acute myeloid leukemia （AML）：Blood and Marrow Transplant Clinical Trials Network （BMT CTN）0901. Blood，2015，126（23）：LBA-8.

5.Scott BL，Pasquini MC，Logan BR，et al. Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes. J Clin Oncol，2017，35：1154-1161.

6.Fasslrinner F，Schetelig J，Burchert A，et al. Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission：retrospective follow-up of an open-label，randomised phase 3 trial. Lancet Haematol，2018，5（4）：e161-e169.

7.Killick SB，Bown N，Cavenagh J，et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol， 2016，172（2）：187-207.

8.Peffault de Latour R，Chevret S，Jubert C，et al. Unrelated cord blood transplantation in patients with acquired refractory aplastic anemia：a nationwide phaseⅡ study. Blood，2018，doi：10.1182/blood-2018-01-829630.［Epub ahead of print］

9.Rambaldi A，Grassi A，Masciulli A，et al. Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia：an open-label，multicentre，randomised，phase 3 trial. Lancet Oncol，2015，16（15）：1525-1536.

10.Kebriaei P，Bassett R，Lyons G，et al. Clofarabine plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in patients with Acute Lymphoblastic Leukemia：Long-Term Study Results. Biol Blood Marrow Transplant，2017，23（2）：285-292.